Neurochemical and histologic characterization of striatal excitotoxic lesions produced by the mitochondrial toxin 3-nitropropionic acid

An impairment of energy metabolism may underlie slow excitotoxic neuronal death in neurodegenerative diseases. We therefore examined the effects of intrastriatal, subacute systemic, or chronic systemic administration of the mitochondrial toxin 3-nitropropionic acid (3-NP) in rats. Following intrastriatal injection 3-NP produced dose-dependent striatal lesions. Neurochemical and histologic evaluation showed that markers of both spiny projection neurons (GABA, substance P, calbindin) and aspiny interneurons (somatostatin, neuropeptide Y, NADPH- diaphorase) were equally affected. Subacute systemic administration of 3-NP produced age-dependent bilateral striatal lesions with a similar neurochemical profile. However, in contrast to the intrastriatal injections, striatal dopaminergic afferent projections were spared. Both freeze-clamp measurements and chemical shift magnetic resonance spectroscopy showed that 3-NP impairs energy metabolism in the striatum in vivo. Microdialysis showed no increase in extracellular glutamate concentrations after systemic administration of 3-NP. The lesions produced by intrastriatal injection or systemic administration of 3-NP were blocked by prior decortication. However, the NMDA antagonist MK- 801 did not block the effects of intrastriatal 3-NP, consistent with a non-NMDA excitotoxic mechanism. In contrast to subacute systemic administration of 3-NP, chronic (1 month) administration produced lesions confined to the striatum in which there was relative sparing of NADPH-diaphorase interneurons, consistent with an NMDA excitotoxic process. Chronic administration showed growth-related proliferative changes in dendrites of spiny neurons similar to changes in Huntington's disease (HD). These results are consistent with in vitro studies showing that mild metabolic compromise can selectively activate NMDA receptors while more severe compromise activates both NMDA and non- NMDA receptors. Chronic administration of 3-NP over 1 month produces selective striatal lesions that replicate many of the characteristic histologic and neurochemical features of HD.

[1]  B. Rosen,et al.  Age‐Dependent Vulnerability of the Striatum to the Mitochondrial Toxin 3‐Nitropropionic Acid , 1993, Journal of neurochemistry.

[2]  D. Choi,et al.  Glutamate neurotoxicity and diseases of the nervous system , 1988, Neuron.

[3]  G. Zeevalk,et al.  Mechanisms underlying initiation of excitotoxicity associated with metabolic inhibition. , 1991, The Journal of pharmacology and experimental therapeutics.

[4]  S. Sagar,et al.  Temporal patterns of somatostatin immunoreactivity in the cerebrospinal fluid of the rhesus monkey: effect of environmental lighting , 1982, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[5]  A. Ludolph,et al.  3-Nitropropionic Acid - Exogenous Animal Neurotoxin and Possible Human Striatal Toxin , 1991, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

[6]  N W Kowall,et al.  Proliferative and degenerative changes in striatal spiny neurons in Huntington's disease: a combined study using the section-Golgi method and calbindin D28k immunocytochemistry , 1991, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[7]  M. Beal,et al.  Substance P‐like immunoreactivity is reduced in Alzheimer's disease cerebral cortex , 1987, Neurology.

[8]  D. Gould,et al.  BASAL GANGLIA DEGENERATION, MYELIN ALTERATIONS, AND ENZYME INHIBITION INDUCED IN MICE BY THE PLANT TOXIN 3‐NITROPROPANOIC ACID , 1982, Neuropathology and applied neurobiology.

[9]  Joseph B. Martin,et al.  Differential sparing of somatostatin‐neuropeptide y and cholinergic neurons following striatal excitotoxin lesions , 1989, Synapse.

[10]  A. Novelli,et al.  Glutamate becomes neurotoxic via the N-methyl-d-aspartate receptor when intracellular energy levels are reduced , 1988, Brain Research.

[11]  J. Rafols,et al.  Golgi study of the mouse striatum: Age‐related dendritic changes in different neuronal populations , 1989, The Journal of comparative neurology.

[12]  R. Uitti,et al.  Cyanide‐induced parkinsonism , 1985, Neurology.

[13]  M. Ito,et al.  Complex I (reduced nicotinamide-adenine dinucleotide-coenzyme Q reductase) deficiency in two patients with probable Leigh syndrome. , 1990, The Journal of pediatrics.

[14]  G. Zeevalk,et al.  Evidence that the Loss of the Voltage‐Dependent Mg2+ Block at the N‐Methyl‐D‐Aspartate Receptor Underlies Receptor Activation During Inhibition of Neuronal Metabolism , 1992, Journal of neurochemistry.

[15]  S. Udenfriend,et al.  Fluorometric assay of proteins in the nanogram range. , 1973, Archives of biochemistry and biophysics.

[16]  J. Martín,et al.  Defect in succinate oxidation by isolated muscle mitochondria in a patient with symmetrical lesions in the basal ganglia , 1988, Journal of the Neurological Sciences.

[17]  Joseph B. Martin,et al.  Amino acid neurotransmitters in postmortem human brain analyzed by high performance liquid chromatography with electrochemical detection , 1987, Journal of Neuroscience Methods.

[18]  Joseph B. Martin,et al.  An examination of neuropeptide Y postmortem stability in an animal model simulating human autopsy conditions , 1986, Neuroscience Letters.

[19]  G. Bruyn,et al.  Hereditary spastic dystonia: A new mitochondrial encephalopathy? Putaminal necrosis as a diagnostic sign , 1991, Journal of the Neurological Sciences.

[20]  Elsdon Storey,et al.  Excitotoxin Lesions in Primates as a Model for Huntington's Disease: Histopathologic and Neurochemical Characterization , 1993, Experimental Neurology.

[21]  G. Zeevalk,et al.  Chemically induced hypoglycemia and anoxia: relationship to glutamate receptor-mediated toxicity in retina. , 1990, The Journal of pharmacology and experimental therapeutics.

[22]  M. Beal,et al.  Does impairment of energy metabolism result in excitotoxic neuronal death in neurodegenerative illnesses? , 1992, Annals of neurology.

[23]  B. Hyman,et al.  Aminooxyacetic Acid Results in Excitotoxin Lesions by a Novel Indirect Mechanism , 1991, Journal of neurochemistry.

[24]  R. Albin,et al.  Alternative excitotoxic hypotheses , 1992, Neurology.

[25]  D. Edmondson,et al.  Inactivation of succinate dehydrogenase by 3-nitropropionate. , 1979, The Journal of biological chemistry.

[26]  P. Mcgeer,et al.  Kainate-induced degeneration of neostriatal neurons: dependency upon corticostriatal tract , 1978, Brain Research.

[27]  B. Rosen,et al.  1‐Methyl‐4‐Phenylpyridinium Produces Excitotoxic Lesions in Rat Striatum as a Result of Impairment of Oxidative Metabolism , 1992, Journal of neurochemistry.

[28]  J. Brierley,et al.  Cyanide intoxication in the rat: physiological and neuropathological aspects. , 1976, Journal of neurology, neurosurgery, and psychiatry.

[29]  Joseph B. Martin,et al.  Replication of the neurochemical characteristics of Huntington's disease by quinolinic acid , 1986, Nature.

[30]  D. Carpenter,et al.  Inhibition of energy metabolism by 3-nitropropionic acid activates ATP-sensitive potassium channels , 1992, Brain Research.

[31]  J. Penney,et al.  NMDA receptor losses in putamen from patients with Huntington's disease. , 1988, Science.

[32]  P. Prior,et al.  Cyanide intoxication in Macaca mulatta Physiological and neuropathological aspects , 1977, Journal of the Neurological Sciences.

[33]  J. Coyle,et al.  Effects of cortical ablation on the neurotoxicity and receptor binding of kainic acid in striatum , 1979, Journal of neuroscience research.